Shreya Mandava, Katherine Gossett, Neil P Monaghan, Shaun A Nguyen, Michelle Hwang, Krishna Patel, Samuel Oyer
{"title":"特发性与非特发性面瘫特征的多机构综述。","authors":"Shreya Mandava, Katherine Gossett, Neil P Monaghan, Shaun A Nguyen, Michelle Hwang, Krishna Patel, Samuel Oyer","doi":"10.1002/lary.32112","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Occult lesions involving the facial nerve can be misdiagnosed as idiopathic facial paralysis, also known as Bell's palsy. Our goal was to compare the clinical features of patients with idiopathic/viral versus non-idiopathic facial paralysis and identify predictors of malignant etiologies.</p><p><strong>Methods: </strong>Retrospective chart review of 276 patients referred for surgical management of facial paralysis at two large facial nerve tertiary care centers.</p><p><strong>Results: </strong>A total of 176 patients had idiopathic/viral facial paralysis (IFP) and 60 patients had non-idiopathic facial paralysis (non-IFP), including malignancies (50/60), benign neoplasms/nerve sheath tumors (8/60), and systemic/CNS disorders (2/60). Non-IFP was more likely to be characterized by gradual onset (57.4% vs. 10.3%; p < 0.01), progressive course (65.0% vs. 19.8%; p < 0.01), irreversible flaccid paralysis (41.7% vs. 10.4%; p < 0.01), and lack of response to medication therapy (71.4% vs. 28.7%; p < 0.01). A past medical history of skin cancer or pre-cancerous lesions (36.4% vs. 7.26%; p < 0.01) and salivary gland cancer (23.3% vs. 0.57%; p < 0.01) were also associated with non-IFP. Epiphora/tearing, facial pain, and facial numbness were associated with malignant FP. 14/60 (23%) patients with non-IFP experienced a diagnostic delay of greater than 6 months.</p><p><strong>Conclusion: </strong>Facial paralysis that is gradual onset (> 72 h), progressive, without synkinesis, and unresponsive to medications should be further evaluated for nonidiopathic causes. Malignant lesions may be associated with other symptoms such as facial pain, facial numbness, and epiphora/tearing. Also consider malignant causes of FP in patients with a history of skin or salivary gland cancer.</p><p><strong>Level of evidence: 3: </strong></p>","PeriodicalId":49921,"journal":{"name":"Laryngoscope","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Multi-Institutional Review of Characteristics of Idiopathic Versus Non-Idiopathic Facial Paralysis.\",\"authors\":\"Shreya Mandava, Katherine Gossett, Neil P Monaghan, Shaun A Nguyen, Michelle Hwang, Krishna Patel, Samuel Oyer\",\"doi\":\"10.1002/lary.32112\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Occult lesions involving the facial nerve can be misdiagnosed as idiopathic facial paralysis, also known as Bell's palsy. Our goal was to compare the clinical features of patients with idiopathic/viral versus non-idiopathic facial paralysis and identify predictors of malignant etiologies.</p><p><strong>Methods: </strong>Retrospective chart review of 276 patients referred for surgical management of facial paralysis at two large facial nerve tertiary care centers.</p><p><strong>Results: </strong>A total of 176 patients had idiopathic/viral facial paralysis (IFP) and 60 patients had non-idiopathic facial paralysis (non-IFP), including malignancies (50/60), benign neoplasms/nerve sheath tumors (8/60), and systemic/CNS disorders (2/60). Non-IFP was more likely to be characterized by gradual onset (57.4% vs. 10.3%; p < 0.01), progressive course (65.0% vs. 19.8%; p < 0.01), irreversible flaccid paralysis (41.7% vs. 10.4%; p < 0.01), and lack of response to medication therapy (71.4% vs. 28.7%; p < 0.01). A past medical history of skin cancer or pre-cancerous lesions (36.4% vs. 7.26%; p < 0.01) and salivary gland cancer (23.3% vs. 0.57%; p < 0.01) were also associated with non-IFP. Epiphora/tearing, facial pain, and facial numbness were associated with malignant FP. 14/60 (23%) patients with non-IFP experienced a diagnostic delay of greater than 6 months.</p><p><strong>Conclusion: </strong>Facial paralysis that is gradual onset (> 72 h), progressive, without synkinesis, and unresponsive to medications should be further evaluated for nonidiopathic causes. Malignant lesions may be associated with other symptoms such as facial pain, facial numbness, and epiphora/tearing. Also consider malignant causes of FP in patients with a history of skin or salivary gland cancer.</p><p><strong>Level of evidence: 3: </strong></p>\",\"PeriodicalId\":49921,\"journal\":{\"name\":\"Laryngoscope\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-03-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Laryngoscope\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/lary.32112\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Laryngoscope","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/lary.32112","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
摘要
目的:累及面神经的隐匿性病变可被误诊为特发性面瘫,又称贝尔麻痹。我们的目的是比较特发性/病毒性与非特发性面瘫患者的临床特征,并确定恶性病因的预测因素。方法:回顾性分析两家大型面神经三级护理中心276例面瘫手术治疗患者的资料。结果:特发性/病毒性面瘫(IFP) 176例,非特发性面瘫(non-IFP) 60例,包括恶性肿瘤(50/60)、良性肿瘤/神经鞘肿瘤(8/60)、全身性/中枢神经系统疾病(2/60)。非ifp更可能以逐渐发病为特征(57.4% vs. 10.3%;p结论:渐进性面瘫(bbb72小时),进行性,无联动性,对药物无反应,应进一步评估非特发性原因。恶性病变可伴有其他症状,如面部疼痛、面部麻木和流泪。同时考虑有皮肤或唾液腺癌病史的患者FP的恶性原因。证据等级:3;
A Multi-Institutional Review of Characteristics of Idiopathic Versus Non-Idiopathic Facial Paralysis.
Objective: Occult lesions involving the facial nerve can be misdiagnosed as idiopathic facial paralysis, also known as Bell's palsy. Our goal was to compare the clinical features of patients with idiopathic/viral versus non-idiopathic facial paralysis and identify predictors of malignant etiologies.
Methods: Retrospective chart review of 276 patients referred for surgical management of facial paralysis at two large facial nerve tertiary care centers.
Results: A total of 176 patients had idiopathic/viral facial paralysis (IFP) and 60 patients had non-idiopathic facial paralysis (non-IFP), including malignancies (50/60), benign neoplasms/nerve sheath tumors (8/60), and systemic/CNS disorders (2/60). Non-IFP was more likely to be characterized by gradual onset (57.4% vs. 10.3%; p < 0.01), progressive course (65.0% vs. 19.8%; p < 0.01), irreversible flaccid paralysis (41.7% vs. 10.4%; p < 0.01), and lack of response to medication therapy (71.4% vs. 28.7%; p < 0.01). A past medical history of skin cancer or pre-cancerous lesions (36.4% vs. 7.26%; p < 0.01) and salivary gland cancer (23.3% vs. 0.57%; p < 0.01) were also associated with non-IFP. Epiphora/tearing, facial pain, and facial numbness were associated with malignant FP. 14/60 (23%) patients with non-IFP experienced a diagnostic delay of greater than 6 months.
Conclusion: Facial paralysis that is gradual onset (> 72 h), progressive, without synkinesis, and unresponsive to medications should be further evaluated for nonidiopathic causes. Malignant lesions may be associated with other symptoms such as facial pain, facial numbness, and epiphora/tearing. Also consider malignant causes of FP in patients with a history of skin or salivary gland cancer.
期刊介绍:
The Laryngoscope has been the leading source of information on advances in the diagnosis and treatment of head and neck disorders since 1890. The Laryngoscope is the first choice among otolaryngologists for publication of their important findings and techniques. Each monthly issue of The Laryngoscope features peer-reviewed medical, clinical, and research contributions in general otolaryngology, allergy/rhinology, otology/neurotology, laryngology/bronchoesophagology, head and neck surgery, sleep medicine, pediatric otolaryngology, facial plastics and reconstructive surgery, oncology, and communicative disorders. Contributions include papers and posters presented at the Annual and Section Meetings of the Triological Society, as well as independent papers, "How I Do It", "Triological Best Practice" articles, and contemporary reviews. Theses authored by the Triological Society’s new Fellows as well as papers presented at meetings of the American Laryngological Association are published in The Laryngoscope.
• Broncho-esophagology
• Communicative disorders
• Head and neck surgery
• Plastic and reconstructive facial surgery
• Oncology
• Speech and hearing defects